Chemedica S.a.

Calculating rank

USPTO Granted Patents = 4

CIPO Patents = 1

Forward Citations = 90

Loading Chart...

5 inventors (with patents filed for the assignee):

Stefano Carlino (1 out of 6 patents)

Guido Di Napoli (1 out of 8 patents)

Amalio Cantoro (1 out of 3 patents)

4. François Magnette (1 out of 1 patent)

5. Rene-Pierre Buenter (1 out of 1 patent)

6. Rene-Pierre Bunter (0 patent)

4 patents: Sort by Forward Citations

1. 6489467 - Process for purifying high molecular weight hyaluronic acid (2002-12-03),

2. 5972909 - Use of hyaluronic acid and corresponding salts for the preparation of an (1999-10-26),

3. 5880107 - Sodium hyaluronate based ophthalmic formulation for use in eye surgery (1999-03-09),

4. 5871772 - Sodium hyaluronate viscous solutions for use as masking fluid in (1999-02-16),

Company Overview

Chemedica S.a. is a global pharmaceutical company that specializes in the development and distribution of ophthalmic and rheumatology products. With a focus on research and innovation, Chemedica provides high-quality solutions for patients worldwide. The company is committed to improving the quality of life for those suffering from eye conditions and rheumatic diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#3 in Vouvry

#2,006 in Switzerland

Vouvry, Switzerland

Chemedica S.a.

Forward Citations = 90

5 inventors:

Stefano Carlino (1 out of 6 patents)

Guido Di Napoli (1 out of 8 patents)

Amalio Cantoro (1 out of 3 patents)

4. François Magnette (1 out of 1 patent)

5. Rene-Pierre Buenter (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chemedica S.a.. Retrieved from https://idiyas.com/company/chemedica-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]